알지노믹스(주) / Rznomics Inc.
Rznomics Inc.'s KOBDi Score is 69.25 as of Sep 2026, up 2.31 points since Apr 2025; it rose in 6 and fell in 3 of the 12 monthly updates. As of Sep 2026 it is ahead of about 95% of companies in its industry, against 95% in Aug 2026 and 86% in Apr 2025. Its strongest position was 96% (Jul 2026) and its weakest 86% (May 2025).
A year earlier, in Aug 2025, its score was 67.86 and it was ahead of about 87% of companies in its industry.
| Sep 2026 | 69.25 | ahead of 95% |
| Aug 2026 | 69.25 | ahead of 95% |
| Jul 2026 | 69.25 | ahead of 96% |
| Jun 2026 | 69.25 | ahead of 96% |
| May 2026 | 68.49 | ahead of 96% |
| Apr 2026 | 68.17 | ahead of 96% |
| Mar 2026 | 69.16 | ahead of 96% |
| Feb 2026 | 69.06 | ahead of 96% |
| Dec 2025 | 68.46 | ahead of 95% |
| Aug 2025 | 67.86 | ahead of 87% |
| Jul 2025 | 67.98 | ahead of 87% |
| May 2025 | 66.63 | ahead of 86% |
| Apr 2025 | 66.95 | ahead of 86% |
| # | ||||
|---|---|---|---|---|
| 에이치엔에이치바이오 주식회사 Hnh Bio Co., Ltd. | 50–99 | #61 | ||
| 갤럭스주식회사 Galux Inc. | 50–99 | #63 | ||
| (주)인투셀 IntoCell, Inc. | 30–49 | #60 | ||
| 메디인테크 Mediintech Co., Ltd. | 50–99 | #64 | ||
| (주)삼양사 식품연구소 | 30–49 | #59 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is Rznomics Inc. located?
Rznomics Inc. is registered at Jukjeon-ro, Suji-gu, Yongin-si, Gyeonggi-do, South Korea (postal code 13486).
What industry is Rznomics Inc. in?
Rznomics Inc. belongs to Professional, Scientific & Technical Services › Research & Development Services › Other humanities and social science research and development.
How many employees does Rznomics Inc. have?
Rznomics Inc. has 30–49 employees.
Is Rznomics Inc. a public company?
Yes. Rznomics Inc. is listed on KOSDAQ under the ticker Not available since 2025.
What is Rznomics Inc.'s KOBDi Score?
69.25 as of September 2026, ahead of about 95% of companies in its industry.
Who are Rznomics Inc.'s competitors?
Similar companies include Hnh Bio, Galux and IntoCell.

